ミシシッピ州における前立腺がんの臨床試験
ミシシッピ州内の拠点で、前立腺がんに関する7件の研究が参加者を募集しています。
ミシシッピ州内の都市
公式研究テキスト（英語）
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Mississippi Medical Center, Jackson
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- Baptist Memorial Hospital and Cancer Center-Oxford, Oxford
被験者募集中第3相
18歳以上 · 男性 · 2026/08/19更新 · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- University of Mississippi Medical Center, Jackson
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University of Mississippi Med Ctr, Jackson
被験者募集中第4相
18歳〜100歳 · 男性 · 2026/06/04更新 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Mississippi Medical Center, Jackson
被験者募集中観察研究
21歳以上 · 男性 · 2026/05/22更新 · NCT03151629Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- University of Mississippi Medical Center, Jackson
被験者募集中第3相
18歳以上 · 男性 · 2026/01/22更新 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。